Highly up-regulated of H19 was demonstrated in a variety of tumors including colorectal cancer (33), hepatocellular cancer (34), breast cancer (35), lung cancers (36), and RCC (20, 30). The gene discussed is H19; the disease is renal cell adenocarcinoma.